TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 33 filers reported holding TREVI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,675 | -16.2% | 34,714 | -8.1% | 0.00% | – |
| Q2 2023 | $90,320 | +12621.1% | 37,791 | +9741.4% | 0.00% | – |
| Q1 2023 | $710 | -16.3% | 384 | -12.5% | 0.00% | – |
| Q4 2022 | $848 | -99.9% | 439 | -99.9% | 0.00% | – |
| Q3 2022 | $660,000 | +65900.0% | 428,405 | +72634.3% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 589 | -41.1% | 0.00% | – |
| Q1 2021 | $3,000 | +200.0% | 1,000 | +777.2% | 0.00% | – |
| Q3 2019 | $1,000 | -97.6% | 114 | -98.0% | 0.00% | – |
| Q2 2019 | $42,000 | – | 5,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 11,370,376 | $24,787,420 | 1.91% |
| Fairmount Funds Management LLC | 5,163,287 | $11,255,966 | 1.35% |
| Opaleye Management Inc. | 1,705,900 | $3,718,862 | 1.21% |
| Frazier Life Sciences Management, L.P. | 6,881,090 | $15,000,776 | 1.00% |
| VR Adviser, LLC | 3,422,397 | $7,460,825 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 927,415 | $2,021,765 | 0.61% |
| Rubric Capital Management LP | 5,684,420 | $12,392,036 | 0.46% |
| Tejara Capital Ltd | 180,227 | $392,895 | 0.22% |
| PFS Partners, LLC | 100,000 | $218,000 | 0.19% |
| WealthTrust Axiom LLC | 93,500 | $203,830 | 0.07% |